The phenomenon of macro-TSH in a patient on oncoimmunotherapy: a clinical case report

View at Publisher

Ask AI

Bookmark

Share

Key Points

Macro-TSH was identified in the patient during oncoimmunotherapy treatment, indicating potential hormonal irregularities.
Clinical case highlights the need to monitor thyroid levels in patients undergoing oncoimmunotherapy, as thyroid function can be impacted.
Analysis of this phenomenon sheds light on the complex interactions between immunotherapy and endocrine functions in patients with cancer treatment plans, emphasizing comprehensive care approaches for managing side effects in these patients: a critical aspect of cancer care decision-making processes firmly embedded within endocrinology practices and guidelines likely to be referenced in future case evaluations.

Answers are grounded in this paper and cite their sources.

Clinical case report discusses macro-TSH occurrence in patient receiving oncoimmunotherapy, implying potential thyroid management insights.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Ebanoidze et al. (2024) studied this question.

View at Publisher

Ask AI

Bookmark

Share